Drug Type Small molecule drug |
Synonyms F06-C40, SLI F06 |
Target |
Action modulators |
Mechanism Collagen modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cicatrix | Phase 2 | United States | 25 Jul 2022 | |
| Wounds and Injuries | Phase 2 | United States | 25 Jul 2022 |
Phase 1/2 | 22 | (SLI-F06) | wnejgglepi(sngzbrocme) = krfcpzluij msbkmauban (qbqgeylpec, 1.7) View more | - | 18 Apr 2023 | ||
Formulation buffer (Formulation Buffer) | wnejgglepi(sngzbrocme) = tlfbbgkvbp msbkmauban (qbqgeylpec, 1.7) View more |





